Waystar Holding Corp. Stock Price, News & Analysis

Waystar (Nasdaq: WAY) has launched Auth Accelerate, a new solution to automate the prior authorization process in healthcare. The innovation reduces submission times by 70% and achieves 85% auto-approval rates, addressing a critical industry challenge that providers have identified as their top investment priority for 2025.

The solution decreases average payer approval wait times by 75%, from over four days to one day or less. This addresses a significant healthcare burden, as a recent American Medical Association survey revealed that over 25% of physicians report prior authorizations leading to serious adverse patient events, while 78% note that delays cause patients to abandon care.

Prisma Health, serving 1.6 million patients annually, is among the first organizations to implement Auth Accelerate. The launch follows Waystar's recent recognition as Best in KLAS for Patient Access solutions and the introduction of Waystar AltitudeAI™, including AltitudeCreate™ for denied claims appeals.

EQT has completed an underwritten public offering of 23 million shares of Waystar Holding Corp (NASDAQ: WAY) common stock, generating total gross proceeds of USD920 million. As part of the offering, EQT sold approximately 9.8 million shares, receiving gross proceeds of about USD393 million, and now holds approximately 38.8 million shares. The remaining shares were sold by other Waystar stockholders.

The offering was managed by J.P. Morgan, Goldman Sachs & Co. , and Barclays as joint book-running managers. Notably, Waystar did not sell any shares in the offering and received no proceeds from the sale of shares by EQT and other stockholders.

Waystar Holding Corp. (Nasdaq: WAY) has announced the pricing of a public offering where certain investment funds of EQT AB, Bain Capital, LP, and Canada Pension Plan Investment Board (the Selling Stockholders) will sell 20,000,000 shares of common stock at $40.00 per share. The Selling Stockholders have also granted underwriters a 30-day option to purchase up to 3,000,000 additional shares.

The offering, expected to close around February 24, 2025, is being led by J.P. Morgan, Goldman Sachs & Co. , and Barclays as joint lead book-running managers. Waystar itself is not selling any shares and will not receive any proceeds from the offering. The transaction is subject to customary closing conditions and has been registered with the SEC.

Waystar Holding Corp. (Nasdaq: WAY) has announced a proposed underwritten public offering of 18,000,000 shares of its common stock. The offering is being made by certain investment funds of EQT AB, Canada Pension Plan Investment Board, and Bain Capital, LP (the Selling Stockholders). The underwriters will have a 30-day option to purchase up to 2,700,000 additional shares.

The offering is being led by J.P. Morgan, Goldman Sachs & Co. , and Barclays as joint lead book-running managers. Importantly, Waystar will not receive any proceeds from the sale of shares in this offering. A registration statement on Form S-1 has been filed with the SEC but has not yet become effective.

Waystar Holding Corp. (WAY) reported strong Q4 and fiscal year 2024 results, with annual revenue reaching $944M, up 19% year-over-year. Q4 revenue grew 18% to $244.1M, with net income of $19.1M and adjusted EBITDA of $100.2M.

The company demonstrated solid performance metrics, including a 110% net revenue retention rate and 1,203 clients contributing over $100,000 in LTM revenue, up 15% YoY. Subscription revenue grew 18% to $121.6M, while volume-based revenue increased 19% to $121.2M.

For fiscal year 2025, Waystar projects revenue between $1.0-1.016B and adjusted EBITDA between $399-407M. The company expects non-GAAP net income of $237-243M and diluted non-GAAP EPS of $1.29-1.32.

Waystar Holding Corp. (Nasdaq: WAY) has been recognized as the leading AI-powered software platform by Black Book Market Research™, securing top rankings in eight categories. The recognition comes from an independent survey of over 1,300 healthcare executives evaluating 80 vendors' AI-powered revenue cycle management solutions.

The company dominated in key areas including claim accuracy, operational efficiency, reduction in administrative burden, and patient engagement. Notably, Waystar outperformed competitors, with no other vendor securing more than one top ranking out of the 18 AI categories.

In January, Waystar launched AltitudeAI™, featuring AltitudeCreate™, a pioneering generative AI capability for appealing denied claims. The platform excels in claim management, showing significant improvements in claim rejection rates, clean claim submissions, and reimbursement turnaround time. Additionally, Waystar leads in patient collections and engagement, offering AI-driven tools that enhance payment collection rates while maintaining patient satisfaction.

Waystar Holding Corp. (Nasdaq: WAY) has secured top rankings in multiple 2025 Best in KLAS categories, specifically in Claims Management & Clearinghouse and Patient Access solutions. The recognition is based on independent client feedback and highlights Waystar's excellence in healthcare payment software.

The company's AI-powered platform, driven by Waystar AltitudeAI™, helps healthcare providers optimize revenue cycle workflows by integrating front-end patient access with back-end claims management. In 2024, Waystar demonstrated industry leadership by successfully implementing its Accelerated Implementation Program, which helped onboard over 30,000 providers during a nationwide cyber incident affecting claims processing.

The company's recent achievements include recognition from Forbes' Most Trusted Companies in America, Fortune's Best Workplaces in Health Care, and multiple Gold Stevie® Awards for cloud-based software and AI leadership. This marks over a dozen consecutive years of Waystar being named Best in KLAS.

Waystar Holding Corp. (Nasdaq: WAY), a healthcare payment software provider, has scheduled its Q4 and fiscal year 2024 financial results announcement for February 18, 2025, before market open. The company will host a conference call at 8:30 a.m. Eastern Time on the same day to discuss the results. A live audio webcast will be available on Waystar's investor relations website, with an archived version accessible for those unable to attend the live event.

Waystar (Nasdaq: WAY) has launched Waystar AltitudeAI™, featuring AltitudeCreate™, a groundbreaking generative AI technology designed to automate the appeal process for denied healthcare claims. The innovation aims to help providers recover substantial portions of payments from over 450 million annually denied claims.

The initiative addresses significant challenges in healthcare administration, where $350 billion is lost annually to administrative waste, and hospitals spend $20 billion yearly attempting to overturn denied claims. More than half of denied claims are ultimately overturned, but the process is traditionally time-consuming and error-prone.

Waystar's platform processes over five billion annual transactions for approximately 50% of patients nationwide. The company's AI capabilities are now unified under the Waystar AltitudeAI™ brand, focusing on improving healthcare payment efficiency and accuracy.